The role of the CXCL10/CXCR3 system in type 1 diabetes

Review of Diabetic Studies

Volumn 6, Issue 2, 2009, Pages 81-84

  Shimada, Akira ^a   Oikawa, Yoichi ^a   Yamada, Yoshifumi ^a   Okubo, Yoshiaki ^a   Narumi, Shosaku ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Beta cell proliferation; CD4; CD45RB; CD8; GAD; IGRP; IL 10; IL 18; Insulitis; NOD; T cell; T helper cell; Th1; Type 1 diabetes

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON INDUCIBLE PROTEIN 10 MONOCLONAL ANTIBODY; GLUTAMATE DECARBOXYLASE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

CELL PROLIFERATION; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; SHORT SURVEY; T LYMPHOCYTE; TH1 CELL;

EID: 70349659962     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.81     Document Type: Short Survey

References (24)

1. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006. 355(13):1318-1330. (Pubitemid 44465460)
2. Sia C. Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus. Rev Diabet Stud 2005. 2(4):182-186.
3. Rotondi M, Lazzeri E, Romagnani P, Serio M. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 2003. 26(2):177-180. (Pubitemid 36503068)
4. Shigihara T, Oikawa Y, Kanazawa Y, Okubo Y, Narumi S, Saruta T, Shimada A. Significance of serum CXCL10/IP-10 level in type 1 diabetes. J Autoimmun 2006. 26(1):66-71. (Pubitemid 43138895)
5. Morimoto J, Yoneyama H, Shimada A, Shigihara T, Yamada S, Oikawa Y, Matsushima K, Saruta T, Narumi S. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis. J Immunol 2004. 173(11):7017-7024. (Pubitemid 39541091)
6. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005. 435(7039):220-223. (Pubitemid 40685949)
7. Funae O, Shimada A, Tokui M, Takei I, Saruta T. Balance of GAD65-specific IL-10 production and polyclonal Th1-type response in type 1 diabetes. Autoimmunity 2001. 34(1):45-52. (Pubitemid 32888275)
8. Shimada A, Rohane P, Fathman CG, Charlton B. Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 1996. 45(1):71-78. (Pubitemid 26010426)
9. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 1996. 45(8):1063-1067. (Pubitemid 26260159)
10. Shimada A, Charlton B, Rohane P, Taylor-Edwards C, Fathman CG. Immune regulation in type 1 diabetes. J Autoimmun 1996. 9(2):263-269.
11. Kanazawa Y, Shimada A, Oikawa Y, Okubo Y, Tada A, Imai T, Miyazaki J, Itoh H. Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetes. J Autoimmun 2009. 32(2):104-109.
12. Oikawa Y, Shimada A, Kasuga A, Morimoto J, Osaki T, Tahara H, Miyazaki T, Tashiro F, Yamato E, Miyazaki J, Saruta T. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice. J Immunol 2003. 171(11):5865-5875. (Pubitemid 37467203)
13. Han B, Serra P, Amrani A, Yamanouchi J, Maree AF, Edelstein-Keshet L, Santamaria P. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat Med 2005. 11(6):645-652. (Pubitemid 40868305)
14. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009. 155(2):173-181.
15. Coppieters KT, von Herrath MG. Histopathology of type 1 diabetes: Old Paradigms and New Insights. Rev Diabet Stud 2009. This issue.
16. Suzuki R, Shimada A, Maruyama T, Funae O, Morimoto J, Kodama K, Oikawa Y, Kasuga A, Matsubara K, Saruta T, Narumi S. T-cell function in anti-GAD65(+)diabetes with residual beta-cell function. J Autoimmun 2003. 20(1):83-90. (Pubitemid 36207630)
17. Shimada A, Morimoto J, Kodama K, Suzuki R, Oikawa Y, Funae O, Kasuga A, Saruta T, Narumi S. Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 2001. 24(3):510-515. (Pubitemid 32198422)
18. Nicoletti F, Conget I, Di Mauro M, Di Marco R, Mazzarino MC, Bendtzen K, Messina A, Gomis R. Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 2002. 45(8):1107-1110. (Pubitemid 34985286)
19. Shimada A, Kodama K, Morimoto J, Oikawa Y, Irie J, Nakagawa Y, Matsubara K, Maruyama T, Saruta T. Detection of GAD-reactive CD4+ cells in so-called "type 1B" diabetes. Ann N Y Acad Sci 2003. 1005:378-386.
20. Itoh A, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Irie J, Nakagawa Y, Shigihara T, Kanazawa Y, Okubo Y, Motohashi Y, Maruyama T, Saruta T. GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9. Ann N Y Acad Sci 2004. 1037:33-40. (Pubitemid 40299740)
21. Shigihara T, Shimada A, Oikawa Y, Yoneyama H, Kanazawa Y, Okubo Y, Matsushima K, Yamato E, Miyazaki J, Kasuga A, Saruta T, Narumi S. CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced beta cell proliferation in NOD mice. J Immunol 2005. 175(12):8401-8408. (Pubitemid 41798407)
22. Yamada S, Irie J, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Saruta T. Assessment of beta cell mass and oxidative peritoneal exudate cells in murine type 1 diabetes using adoptive transfer system. Autoimmunity 2003. 36(2):63-70. (Pubitemid 36394874)
23. Schulthess FT, Paroni F, Sauter NS, Shu L, Ribaux P, Haataja L, Strieter RM, Oberholzer J, King CC, Maedler K. CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab 2009. 9(2):125-139.
24. Okubo Y, Shimada A, Kanazawa Y, Shigihara T, Oikawa Y, Imai T, Miyazaki J, Itoh H. Hyperplastic islets observed in "reversed" NOD mice treated without hematopoietic cells. Diabetes Res Clin Pract 2008. 79(1):18-23.